We’re excited to share that our experts, Lidia Cánovas and Carlos Domingo, will be attending the 2025 Biosimilar Medicines Conference by MFE!
This event is a key gathering for industry leaders, regulators, policymakers, and healthcare professionals shaping the future of biosimilar medicines. With discussions on access, regulatory science, market competition, and innovation, it’s an unmissable opportunity to exchange insights on the evolving biosimilar landscape.
Let´s meet! If you’re attending and want to discuss your regulatory requirements, compliance strategies, or other challenges, don’t hesitate to reach out at [email protected]. We’d love to connect!
